Clinical trial
Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the…
NCT00216333 · International Union Against Tuberculosis and Lung Diseases, Other · Unknown status
Key facts
| NCT number | NCT00216333 |
|---|---|
| Title | Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis |
| Official title | International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis |
| Lead sponsor | International Union Against Tuberculosis and Lung Diseases, Other |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | combined fixed dose combination |
| Enrollment | 1,500 |
| Start date | Dec 1, 2003 |
| Completion | Jun 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 13, 2006 |
| Countries | Algeria, Bolivia, Colombia, Guinea, Mozambique, Nepal, Peru, Tanzania, Vietnam |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: